Arcadia & Datavant Partner to Accelerate Whole-Person Care & Biopharma Research

 Arcadia Partners with Datavant to Accelerate Whole-Person Care & Biopharma Research

What You Should Know:

– Arcadia and Datavant today announced a partnership to enable de-identified connectivity of Arcadia’s electronic health record data for life sciences research and commercial analytics.

– This partnership will unlock fresh insights to accelerate whole-person care and biopharma research, extending Arcadia’s leadership in empowering a data-driven transformation of healthcare.

– Datavant will allow clients to connect Arcadia data to other types of Real World Data (RWD) available in Datavant’s ecosystem of more than 500 partners including insurance claims, labs, imaging, social determinants, devices, and other data that describe patient health.

Datavant will enable connectivity to Arcadia’s de-identified electronic health record data

Using Datavant, life sciences and research organizations will be able to leverage Arcadia’s data for health economics and outcomes research, medical affairs, and commercial analyses. This partnership will unlock fresh insights to accelerate whole-person care, extending Arcadia’s leadership in empowering a data-driven transformation of healthcare and enabling happier, healthier lives for all. Datavant will allow clients to connect Arcadia data to other types of RWD available in Datavant’s ecosystem of more than 500 partners including insurance claims, labs, imaging, social determinants, devices, and other data that describe patient health.

“Longitudinal clinical data is one of the most important emerging data sources reflecting patient’s entire health journey,” noted Travis May, Founder and President of Datavant. “We are excited to work with Arcadia to enable life sciences companies to advance their research through the privacy-compliant use of electronic health record data.”